Siemens Healthineers opens the week with clear consensus, shares in the DAX healthcare mix
23.06.2026 - 17:15:39 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 17:13.
Siemens Healthineers (DE000SHL1006) starts the new week with a steady analyst backdrop and a prominent position in the DAX and TecDAX healthcare segment. Consensus data from MarketScreener and other platforms indicate a broadly positive stance on the shares and keep the stock on the radar of investors comparing it with Fresenius and Merck in Frankfurt trading.
What the consensus shows
Analyst overviews compiled by MarketScreener show Siemens Healthineers covered by a double-digit number of research houses, with the majority of ratings clustered in the Buy and Hold categories, and only a minority on the Sell side according to the latest consensus snapshot. Marketscreener valuation data indicate a current price in the mid-30 euro range and embed the stock in the broader European healthcare peer comparison.
The same consensus summary also provides forward-looking valuation ratios for Siemens Healthineers, such as projected price-earnings and enterprise-value-to-EBITDA multiples based on analyst estimates for the next fiscal years, which position the company at a premium to some domestic healthcare peers but in line with large diagnostic and imaging names globally. These metrics are one reason institutional investors continue to track the stock closely within DAX and Stoxx Europe 600 healthcare allocations.
How the shares trade today
On Xetra, Siemens Healthineers shares most recently changed hands around 34.6 euros during Tuesday trading, with Finanznachrichten showing a small daily gain of roughly 0.3 percent by late afternoon, underlining a calm start to the week for the DAX and TecDAX constituent. The Xetra order book overview lists intraday prints in the mid-34 euro range and places the stock within a relatively narrow intraday trading band.
Price history data compiled by Simply Wall St and other analytical platforms show Siemens Healthineers shares down on a five-year view but with a more stable performance over the past twelve months as the company navigates industry cycles and capital expenditure trends in global hospital and imaging demand. The Simply Wall St profile also highlights the group’s diversified geographic exposure, including the United States, Europe and Asia, which is a relevant factor for volatility and currency sensitivity in the shares.
All news and analysis on the Siemens Healthineers shares
More background, company news and price data on Siemens Healthineers can be found in the dedicated topic section and via the Investor Relations hub.
The medical imaging focus
Siemens Healthineers generates a substantial share of its revenue from advanced medical imaging systems, notably its line of computed tomography scanners and magnetic resonance imaging systems installed in hospitals worldwide. The company also offers related software and service contracts, which provide recurring revenue streams alongside the sale of the equipment itself.
Where the stock trades now
The Siemens Healthineers shares (DE000SHL1006) trade on Xetra at about 34.6 euros as of 2026-06-23, 17:05.
Key data on the Siemens Healthineers shares
- Company: Siemens Healthineers AG
- ISIN: DE000SHL1006
- WKN: SHL100
- Ticker: SHL
- Trading venue: Xetra
- Price (as of 2026-06-23, 17:05): 34.60 EUR
- Market cap: 38.0 billion EUR (as of 2026-06-23)
- Sector / industry: Health Care Equipment & Supplies
- Index membership: DAX, TecDAX, Stoxx Europe 600
- Next earnings date: 2026-08-01
This text is for informational purposes only and does not constitute investment advice, investment recommendation or an invitation to buy or sell securities. Past performance is not a reliable indicator of future results.
